Benefits of blockchain in limiting counterfeit drug distribution
European Pharmaceutical Review
MAY 22, 2023
The review stated that therapeutic innovation has resulted in the production of expensive drugs to treat rare diseases, which need to be available on time. For instance, these drugs must be equipped with real-time insights. This can reduce the willingness for counterfeit and less accurate data, according to the review.
Let's personalize your content